Provided by Tiger Trade Technology Pte. Ltd.

Pacira Pharmaceuticals

25.36
+0.20000.79%
Post-market: 25.360.00000.00%19:30 EDT
Volume:538.04K
Turnover:13.66M
Market Cap:1.01B
PE:72.09
High:25.57
Open:25.43
Low:25.18
Close:25.16
52wk High:27.66
52wk Low:18.80
Shares:39.86M
Float Shares:36.37M
Volume Ratio:0.97
T/O Rate:1.48%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.3518
EPS(LYR):0.1578
ROE:2.05%
ROA:1.48%
PB:1.50
PE(LYR):160.68

Loading ...

Pacira Q1 FY26 net income drops 39% to USD 2.9 million; revenue rises 5% to USD 177 million

Reuters
·
May 01

BRIEF-Pacira Biosciences Q1 Revenue USD 177 Million Vs. IBES Estimate USD 173.3 Million

Reuters
·
May 01

Pacira BioSciences Q1 Adj. EPS $0.60 Beats $0.56 Estimate, Sales $177.376M Beat $173.325M Estimate

Benzinga Earnings
·
May 01

Pacira Biosciences Inc - Reiterates 2026 Guidance

THOMSON REUTERS
·
May 01

Pacira Biosciences Q1 Cash & Investments USD 202.2 Million

THOMSON REUTERS
·
May 01

Pacira urges vote for board slate as activist DOMA pushes company sale at June 9 meeting

Reuters
·
Apr 29

Real-World Data on EXPAREL® Shows Reduced Opioid Use and Lower Total Medical Costs in Medicare Patients Undergoing Total Hip Arthroplasty

GlobeNewswire
·
Apr 27

Pacira CFO Shawn Cross disposes of 12,941 common shares for $325,597.56

Reuters
·
Apr 25

Earning Preview: Pacira Pharmaceuticals this quarter’s revenue is expected to decrease by 1.35%, and institutional views are bullish

Earnings Agent
·
Apr 24

Pacira CFO Shawn Cross disposes 12,059 common shares for $303,299.99

Reuters
·
Apr 23

A Look At Pacira BioSciences (PCRX) Valuation After New EXPAREL Health Economic Data

Simply Wall St.
·
Apr 21

H.C. Wainwright Reaffirms Their Buy Rating on Pacira Pharmaceuticals (PCRX)

TIPRANKS
·
Apr 20

Pacira to report first-quarter results after market close, host conference call

Reuters
·
Apr 16

Pacira real-world study shows EXPAREL lowers costs in outpatient hip replacements

Reuters
·
Apr 13

Pacira to join Needham Virtual Healthcare Conference fireside chat

Reuters
·
Apr 08

Pacira grants inducement equity awards to new hires, sets options exercise price at $22.7

Reuters
·
Apr 08

Pacira says EXPAREL lowers total cost of care in real-world orthopedic studies

Reuters
·
Mar 30

Pacira BioSciences Is Maintained at Equal-Weight by Barclays

Dow Jones
·
Mar 26

J.P. Morgan Sticks to Their Sell Rating for Pacira Pharmaceuticals (PCRX)

TIPRANKS
·
Mar 20

Pacira BioSciences Chief Medical Officer Jonathan Slonin disposes of USD 74,411 in common shares

Reuters
·
Mar 20